Our comprehensive research program advances both high-intensity and low-intensity focused ultrasound applications. Rigorous preclinical validation supports clinical translation.
Low-Intensity Brain Treatment
Reversible neuromodulation for epilepsy and psychiatric disorders. Blood-brain barrier opening enables targeted drug delivery.
· Sub-ablative acoustic energy delivery
· Millimeter precision neural targeting
· Repeated treatments without tissue damage
Preclinical TestingComprehensive safety validation in animal models. Beagle seizure studies with EEG monitoring. Rabbit and canine prostate ablation studies.
Regulatory PathwaysCollaborative regulatory submission preparation. Safety documentation complete. Clinical trial design finalized.
Neurology
Women's Health
Oncology
Pain ManagementThermal ablation with sub-millimeter precision. Minimally invasive alternative to radical
prostatectomy.
· Focal therapy preserves healthy tissue
· Robotic positioning ensures accuracy
· Single-session outpatient treatment
Optimized imaging sequences for targeting. Real-time thermometry refinement. Treatment verification protocols established.
Partnership with Gil Medical Center and Samsung Medical Center. First-in-human trials anticipated within 18-24 months.


Non-Invasive Treatment
No surgical incisions required. Minimal infection risk compared to traditional surgery. Reduced procedural complications.Precision & SafetyReal-time MRI thermometry monitors thermal delivery. Continuous temperature tracking protects healthy tissue. Optimal therapeutic effect.
Faster RecoveryOutpatient procedures reduce hospital stays. Shorter recovery periods. Quicker return to daily activities.